Diginex Shares Under Pressure as Acquisition Funding Falters
25.12.2025 - 13:33:05Diginex KYG286871044
Shares of Diginex have been in a sustained decline for weeks, with a particularly sharp drop of over 34% recorded in December alone. The persistent weakness stems from the company's admission that funding for a key acquisition is now in doubt. In a related development, two other planned deals have been halted.
In an update released shortly before the holidays, management disclosed troubling news regarding its acquisition strategy. While the contractual terms for the planned takeover of Resulticks have been negotiated and documents updated, Diginex openly concedes that securing the cash component of the transaction is currently uncertain.
This admission carries significant weight, as the market had anticipated a smooth execution. The revelation of potential funding shortfalls for a strategically important deal strikes directly at investor confidence. This overhang of uncertainty is likely to persist until Diginex can provide clarity on how it will raise the necessary capital.
Expansion Plans Narrow as Deals Are Halted
Beyond the issues plaguing the Resulticks deal, the company's management has scrapped two other acquisition initiatives. The proposed takeover of Findings (IDRRA Cyber Security Ltd.) has been paused after due diligence reviews failed to yield the expected progress.
The termination was even more definitive for the "Kindred OS" deal. Diginex stated there is no longer a basis to continue negotiations, as preliminary examinations did not produce substantive results, making a successful conclusion unlikely.
Should investors sell immediately? Or is it worth buying Diginex?
A single bright spot exists: The acquisition of The Remedy Project was finalized on December 18. This transaction is intended to bolster the company's position in supply chain compliance and ESG data.
Financial and Technical Weakness Persists
From a chart perspective, the equity appears battered. The severe December sell-off has driven the share price down to $7.30. A sustained recovery seems unlikely while fundamental questions remain unanswered. The company's negative cash flow of -$3.41 per share further highlights the strained financial position.
The current narrative is dominated by the combination of operational losses and the unresolved funding for its expansion strategy. Pressure on the stock is expected to continue until Diginex can provide credible evidence of secured financing for the Resulticks acquisition.
Key Data Points:
* Share price declined 34.23% in December to $7.30
* Cash portion of the Resulticks acquisition is not secured
* Two planned deals have been paused or terminated
* Negative cash flow per share of -$3.41
Ad
Diginex Stock: Buy or Sell?! New Diginex Analysis from December 25 delivers the answer:
The latest Diginex figures speak for themselves: Urgent action needed for Diginex investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 25.
Diginex: Buy or sell? Read more here...


